Super Avana (avanafil + dapoxetine)
Super Avana combines avanafil 100 mg with dapoxetine 60 mg. Understand the two ingredients and the cautions for this combination.
- Active ingredients
- Avanafil + Dapoxetine
- Form
- Tablet
- Company
- Sunrise Remedies Pvt Ltd
Super Avana is listed by Sunrise Remedies as avanafil 100 mg plus dapoxetine 60 mg. Plain Avana has a separate avanafil-only record. The added PE ingredient is the important distinction, rather than the word “Super.”
Fast onset does not validate the fixed combination
The rapid-onset avanafil trial studied a defined erection/intercourse endpoint with avanafil versus placebo. It did not test Super Avana, establish its release design or measure the response to this fixed partner amount. Quoting the earliest avanafil result as a guarantee for the combination would mix different evidence questions.
Avanafil and dapoxetine also bring different interaction and tolerability considerations. A short advertised onset does not eliminate CYP3A4 restrictions, nitrate incompatibility or the serotonergic and fainting review for the PE component.
Match treatment goals before convenience
Selected clinical research has assessed added dapoxetine in men already on stable PDE5 treatment, while some regional Priligy information advises against PDE5 co-use. Neither is a universal endorsement of every avanafil–dapoxetine tablet.
The Sunrise listing is useful identity evidence, but the exact local product information and patient assessment still need to cover both conditions. A person with erection difficulty alone should not assume that a second ingredient adds value. The ED and PE guide explains the separate questions a fixed combination can obscure.
Product record
- Company
- Sunrise Remedies Pvt Ltd
- Strengths listed
- Avanafil 100 mg + dapoxetine 60 mg
- Treatment area
- Erectile dysfunction (ED); Premature ejaculation (PE)
- Where we found it
- In October 2026 we found it in Sunrise Remedies’ own catalogue, not in the Indian retail pharmacy databases we checked. Absence from the retail databases checked does not establish export-only status or current availability.
- Record reviewed
- 4 October 2026; source retrieval dates are retained with the evidence
Listed strengths identify a product; they are not dosing advice. A listing in one country does not show that a product is authorized where you live.
About avanafil
Avanafil has early-response evidence, but timing instructions depend on strength and regional label. Early-attempt trial results are not a guarantee or an active-drug comparison. CYP3A4 inhibitors and blood-pressure interactions matter.
About dapoxetine
Dapoxetine has defined regional PE indications and on-demand trial evidence. Control and distress matter as well as measured minutes. Fainting, alcohol and interacting medicines need review; standalone evidence does not validate every ED/PE combination.
About Indian brands
Indian-company brands have different retail and catalogue evidence. A pharmacy database entry does not establish current stock, and absence from a checked database does not prove export-only manufacture. Company association, exact product identity and local authorization are separate questions.
About fixed combinations
A fixed combination puts two medicines in one tablet at set doses. Each ingredient brings its own side effects and interactions, and approval of each ingredient on its own does not mean the combination is approved or suitable.
Do not add another ED or PE medicine to a combination product.
Using a PDE5 inhibitor safely
Never take a PDE5 inhibitor with nitrates, recreational nitrites (“poppers”) or riociguat, and do not combine two ED medicines. Seek urgent medical help for chest pain, an erection lasting more than four hours, or sudden loss of vision or hearing.
Common side effects include headache, flushing, indigestion and a blocked nose.
Sources
4 sources
Checked .
- Super Avana — Sunrise Remedies (manufacturer site)
- Sunrise Remedies product catalogue — Sunrise Remedies (manufacturer site)
- Avanafil tablets: US prescribing information — DailyMed, US National Library of Medicine. Ingredient reference; it does not describe this brand.
- Priligy (dapoxetine 30 mg) Australian register entry — Therapeutic Goods Administration (Australia). Ingredient reference; it does not describe this brand.